Author,Exposure,Outcome,Direction,Strength,ID,Status
,Diabetes,Ischemic stroke,Increase,6.0,01,Final
,age,Ischemic stroke,Increase,6.0,01,Final
,age,Diabetes,Increase,5.0,01,Final
,Sex (Male),Ischemic stroke,Increase,6.0,01,Final
,Hypertension,Ischemic stroke,Increase,6.0,01,Final
,age,Hypertension,Increase,6.0,01,Final
,BMI,Hypertension,Increase,4.0,01,Final
,BMI,Diabetes,Increase,4.0,01,Final
,BMI,Ischemic stroke,Increase,6.0,01,Final
Carrero et al (2018),Atrial fibrillation,Ischemic stroke,Increase,6.0,01,Final
de Leeuw et al. (2000),Sex (Male),Atrial fibrillation,Increase,4.0,01,Final
Kalantarian et al. (2014),age,Atrial fibrillation,Increase,5.0,01,Final
,BMI,Atrial fibrillation,Increase,6.0,01,Final
Diez-Villanueva P & Alfonso F. (2019),Hypertension,Atrial fibrillation,Increase,6.0,01,Final
,Smoking,Ischemic stroke,Increase,5.0,01,Final
,age,Smoking,Increase,5.0,01,Final
Pan et al. (2019),Sex (Male),Smoking,Increase,6.0,01,Final
Shah & Cole (2010),Smoking,Diabetes,Increase,4.0,01,Final
,Smoking,BMI,Decrease,2.0,01,Final
,Smoking,Hypertension,Increase,3.0,01,Final
Campagna et al. (2019),Smoking,Atrial fibrillation,Increase,6.0,01,Final
Maddatu et al. (2017),Hyperlipidemia,Atrial fibrillation,Increase,6.0,01,Final
Patel et al. (2011),Hyperlipidemia,BMI,Increase,6.0,01,Final
Watanabe et al. (2016),Hyperlipidemia,Hypertension,Increase,6.0,01,Final
Halperin et al. (2008),Hyperlipidemia,Diabetes,Increase,6.0,01,Final
,Hyperlipidemia,Ischemic stroke,Increase,6.0,01,Final
,Diabetes,Atrial fibrillation,Increase,5.0,01,Final
,Smoking,Hyperlipidemia,Increase,3.0,01,Final
,Sex (Male),Diabetes,Increase,3.0,01,Final
,Diabetes,Hypertension,Increase,2.0,01,Final
,Hyperlipidemia,GFR,Decrease,2.0,01,Final
Bohne et al. (2019),Sex (Male),BMI,Decrease,2.0,01,Final
Sensi et al. (2015),Hypertension,GFR,Decrease,2.0,01,Final
Hallit et al. (2017),Diabetes,GFR,Increase,3.0,01,Final
Jain & Ducatman (2018),Smoking,CKD,Increase,3.0,01,Final
Kautzky-Willer et al. (2016),CKD,Atrial fibrillation,Increase,2.0,01,Final
Wishner (1996),CKD,Ischemic stroke,Increase,4.0,01,Final
,NIHSS_stroke,NIHSS_followup,Increase,6.0,02,Final
,NIHSS_stroke,mRS_follow_up,Increase,6.84,02,Final
,mRS_stroke,mRS_follow_up,Increase,6.84,02,Final
,mRS_stroke,NIHSS_followup,Increase,6.84,02,Final
,lesion_size,NIHSS_stroke,Increase,6.84,02,Final
,lesion_size,mRS_stroke,Increase,6.84,02,Final
,lesion_size,mRS_follow_up,Increase,6.84,02,Final
,lesion_size,NIHSS_followup,Increase,6.84,02,Final
,time_to_therapy,NIHSS_followup,Increase,6.84,02,Final
,time_to_therapy,mRS_follow_up,Increase,6.84,02,Final
,lesion_size,Barthel_Index_stroke,Decrease,6.0,02,Final
eloquent / non-eloquent,lesion_location,Barthel_Index_stroke,Decrease,6.0,02,Final
eloquent / non-eloquent,lesion_location,NIHSS_stroke,Increase,6.84,02,Final
eloquent / non-eloquent,lesion_location,NIHSS_followup,Increase,6.84,02,Final
eloquent / non-eloquent,lesion_location,mRS_follow_up,Increase,6.84,02,Final
eloquent / non-eloquent,lesion_location,mRS_stroke,Increase,6.84,02,Final
,NIHSS_stroke,Barthel_Index_follow_up,Decrease,6.0,02,Final
,mRS_stroke,Barthel_Index_follow_up,Decrease,6.0,02,Final
,lesion_size,Barthel_Index_follow_up,Decrease,6.0,02,Final
,time_to_therapy,Barthel_Index_follow_up,Decrease,6.0,02,Final
,Barthel_Index_stroke,Barthel_Index_follow_up,Increase,6.84,02,Final
eloquent/non eloquent,lesion_location,Barthel_Index_follow_up,Decrease,6.0,02,Final
,TOAST (etiology),lesion_size,Increase,6.0,02,Final
,TOAST (etiology),lesion_location,Increase,6.0,02,Final
cardioembolic,present atrial fibrillation,TOAST (etiology),Increase,2.68,02,Final
,time_till_diagnosis,time_to_therapy,Increase,2.68,02,Final
meaning the general population being aware of typical stroke symptoms,awareness of FAST-Scheme,time_till_diagnosis,Decrease,2.0,02,Final
,time_till_diagnosis,rate of thrombolysis,Decrease,6.84,02,Final
,time_till_diagnosis,rate of thrombectomy,Decrease,6.84,02,Final
,rate of thrombolysis,lesion_size,Decrease,2.93,02,Final
,rate of thrombectomy,lesion_size,Decrease,2.93,02,Final
cardioembolic,TOAST (etiology),rate of thrombolysis,Increase,2.93,02,Final
accesible arteries,TOAST (etiology),rate of thrombectomy,Increase,2.68,02,Final
macroangiopathic,arteriosklerosis,TOAST (etiology),Increase,2.68,02,Final
,smoking,arteriosklerosis,Increase,6.84,02,Final
,Age,arteriosklerosis,Increase,6.84,02,Final
,Diabetes mellitus,arteriosklerosis,Increase,6.84,02,Final
,Dyslipidemia,arteriosklerosis,Increase,6.84,02,Final
,Lipoprotein (a),arteriosklerosis,Increase,6.84,02,Final
,Vasculitis,arteriosklerosis,Increase,6.84,02,Final
cardioembolic,persistent foramen ovale,TOAST (etiology),Increase,6.84,02,Final
,hypertension,first ischemic stroke,Increase,6.0,03,Draft
,BMI_t0,first ischemic stroke,Increase,6.84,03,Draft
,age,first ischemic stroke,Increase,6.84,03,Draft
,sex(being male),first ischemic stroke,Increase,6.84,03,Draft
,smoking,first ischemic stroke,Increase,6.84,03,Draft
,diabetes,first ischemic stroke,Increase,6.84,03,Draft
,high blood cholesterol levels,first ischemic stroke,Increase,6.84,03,Draft
,high drinking levels,first ischemic stroke,Increase,6.84,03,Draft
,high fat salt diet,first ischemic stroke,Increase,6.0,03,Draft
,high fat salt diet,hypertension,Increase,2.68,03,Draft
,atrial fibrillation,first ischemic stroke,Increase,6.0,03,Draft
,Atherosclerosis,first ischemic stroke,Increase,6.84,03,Draft
,high fat salt diet,Atherosclerosis,Increase,0.57,03,Draft
,BMI_t1,second ischemic stroke,Increase,0.57,03,Draft
,first ischemic stroke,BMI_t1,Decrease,0.57,03,Draft
,smoking,second ischemic stroke,Increase,6.84,03,Draft
,age,second ischemic stroke,Increase,6.84,03,Draft
,sex(being male),second ischemic stroke,Increase,6.84,03,Draft
,high drinking levels,second ischemic stroke,Increase,6.84,03,Draft
,high fat salt diet,second ischemic stroke,Increase,6.84,03,Draft
,diabetes,second ischemic stroke,Increase,6.84,03,Draft
,arterial hypertension,endothelial dysfunction,Increase,6.84,04,Draft
,Thrombolysis,functional post stroke outcome,Increase,2.68,04,Draft
,lesion size,functional post stroke outcome,Decrease,6.26,04,Draft
,arterial hypertension,functional post stroke outcome,Decrease,6.84,04,Draft
,Obesity,functional post stroke outcome,Decrease,6.84,04,Draft
,Obesity,endothelial dysfunction,Increase,4.61,04,Draft
,endothelial dysfunction,EMV,Increase,6.84,04,Draft
,Obesity,1. stroke incidence,Increase,6.84,04,Draft
,arterial hypertension,1. stroke incidence,Increase,6.84,04,Draft
,1. stroke incidence,functional post stroke outcome,Decrease,1.0,04,Draft
,endothelial dysfunction,1. stroke incidence,Increase,5.42,04,Draft
,EMV,secondary cardiovascular risk,Increase,6.84,04,Draft
,arterial hypertension,secondary cardiovascular risk,Increase,6.84,04,Draft
,endothelial dysfunction,secondary cardiovascular risk,Increase,2.0,04,Draft
,EMV,1. stroke incidence,Increase,4.0,04,Draft
,1. stroke incidence,lesion size,Increase,6.84,04,Draft
,1. stroke incidence,secondary cardiovascular risk,Increase,6.84,04,Draft
,lesion size,secondary cardiovascular risk,Increase,3.0,04,Draft
,vascular inflammation,secondary cardiovascular risk,Increase,6.84,04,Draft
,endothelial dysfunction,vascular inflammation,Increase,3.14,04,Draft
,vascular inflammation,LMV,Increase,5.31,04,Draft
,LMV,secondary cardiovascular risk,Increase,5.31,04,Draft
,Smoking,Stroke,Increase,6.0,05,Draft
,kidney disease,Stroke,Increase,5.0,05,Draft
,male sex,Stroke,Increase,1.0,05,Draft
,exercise,Stroke,Decrease,4.0,05,Draft
,male sex,Smoking,Increase,1.0,05,Draft
,BMI,Stroke,Increase,5.0,05,Draft
,exercise,BMI,Decrease,6.0,05,Draft
,dyslipidemia,Stroke,Increase,5.2,05,Draft
,exercise,kidney disease,Decrease,2.0,05,Draft
,low socioeconomic status,Stroke,Increase,1.75,05,Draft
,Stroke,Depression,Increase,3.84,05,Draft
,Stroke,Cognitive dysfunction,Increase,3.84,05,Draft
,Stroke,Mortality,Increase,6.84,05,Draft
Broersen et al. 2020,hs cardiac Troponin,Stroke,Increase,0.94,05,Draft
,cardiac disease,hs cardiac Troponin,Increase,5.1,05,Draft
,cardiac disease,Stroke,Increase,6.84,05,Draft
,exercise,cardiac disease,Decrease,6.84,05,Draft
,Smoking,cardiac disease,Increase,6.26,05,Draft
,elevated CRP,Stroke,Increase,3.92,05,Draft
,low socioeconomic status,Depression,Increase,3.92,05,Draft
,age,Stroke,Increase,6.84,05,Draft
,age,cardiac disease,Increase,6.84,05,Draft
,high fat/ high carbonhydrate diet,arterial hypertension,Increase,5.0,05,Draft
,high fat/ high carbonhydrate diet,cardiac disease,Increase,5.0,05,Draft
,dyslipidemia,Depression,Increase,3.29,05,Draft
,dyslipidemia,Cognitive dysfunction,Increase,3.29,05,Draft
,vascular disease,Stroke,Increase,6.84,05,Draft
,age,vascular disease,Increase,3.44,05,Draft
,vascular disease,kidney disease,Increase,6.84,05,Draft
,diabetes,kidney disease,Increase,6.84,05,Draft
,diabetes,Stroke,Increase,6.84,05,Draft
,high fat/ high carbonhydrate diet,dyslipidemia,Increase,6.84,05,Draft
,high fat/ high carbonhydrate diet,diabetes,Increase,6.84,05,Draft
,high fat/ high carbonhydrate diet,elevated CRP,Increase,3.68,05,Draft
,Depression,Mortality,Increase,6.0,05,Draft
,coping mechnisms,Depression,Decrease,6.84,05,Draft
,low socioeconomic status,high fat/ high carbonhydrate diet,Increase,2.93,05,Draft
,habitual alcohol consumption,Stroke,Increase,6.84,05,Draft
,habitual alcohol consumption,diabetes,Increase,6.84,05,Draft
,habitual alcohol consumption,coping mechnisms,Decrease,6.13,05,Draft
,exercise,coping mechnisms,Increase,0.51,05,Draft
,exercise,arterial hypertension,Decrease,2.72,05,Draft
,exercise,Stroke,Decrease,6.84,05,Draft
,exercise,Mortality,Decrease,6.84,05,Draft
,Inflammation,Mortality,Increase,5.0,05,Draft
,Inflammation,elevated CRP,Increase,6.84,05,Draft
,Inflammation,Cognitive dysfunction,Increase,1.63,05,Draft
,Inflammation,Depression,Increase,0.51,05,Draft
,habitual alcohol consumption,Inflammation,Increase,3.44,05,Draft
,low socioeconomic status,habitual alcohol consumption,Increase,3.44,05,Draft
,arterial hypertension,cardiac disease,Increase,6.84,05,Draft
,Cognitive dysfunction,coping mechnisms,Decrease,2.45,05,Draft
,Inflammation,vascular disease,Increase,4.17,05,Draft
,high fat/ high carbonhydrate diet,Inflammation,Increase,4.17,05,Draft
,Inflammation,cardiac disease,Increase,4.17,05,Draft
,arterial hypertension,Stroke,Increase,6.84,05,Draft
McCarthy 2018,acute heart failure,myocardial infarction (type 2),Increase,6.0,06,Final
,acute heart failure,mortality,Increase,6.84,06,Final
,acute heart failure,nt-pro-BNP,Increase,6.0,06,Final
,age,diabetes,Increase,4.52,06,Final
,age,FIRST ISCHEMIC STROKE,Increase,6.84,06,Final
,age,atrial fibrillation,Increase,4.34,06,Final
"Bishop, Lu, & Yankner, 2010",age,kognitive decline,Increase,4.0,06,Final
,age,atherosclerosis,Increase,6.84,06,Final
Diener 2020,anticoagulation,second ischemic stroke,Decrease,3.0,06,Final
Diener 2020,anticoagulation,FIRST ISCHEMIC STROKE,Decrease,3.0,06,Final
,anticoagulation,cardiac thrombus,Decrease,2.72,06,Final
,atherosclerosis,FIRST ISCHEMIC STROKE,Increase,6.68,06,Final
,atherosclerosis,myocardial infarction (type 1),Increase,6.84,06,Final
,atrial fibrillation,FIRST ISCHEMIC STROKE,Increase,6.84,06,Final
,atrial fibrillation,troponin elevation,Increase,6.0,06,Final
,atrial fibrillation,nt-pro-BNP,Increase,6.0,06,Final
,atrial fibrillation,severe arrrhythmia,Increase,6.0,06,Final
,BMI,myocardial infarction (type 1),Increase,6.84,06,Final
,BMI,second ischemic stroke,Increase,6.84,06,Final
,BMI,FIRST ISCHEMIC STROKE,Increase,4.34,06,Final
Rizas et al 2017,cardiac autonomic dysbalance,severe arrrhythmia,Increase,4.0,06,Final
,cardiac thrombus,FIRST ISCHEMIC STROKE,Increase,5.1,06,Final
,chronic heart failure,kognitive decline,Increase,4.52,06,Final
,chronic heart failure,FIRST ISCHEMIC STROKE,Increase,4.34,06,Final
,chronic heart failure,nt-pro-BNP,Increase,3.22,06,Final
,chronic heart failure,troponin elevation,Increase,6.0,06,Final
,depression,higher fitness/mobility post,Decrease,2.68,06,Final
,depression,mortality,Increase,2.68,06,Final
Ghadri 2018,depression,Takotsubo syndrome,Increase,2.0,06,Final
,diabetes,mortality,Increase,4.52,06,Final
,diabetes,infection,Increase,3.22,06,Final
,diabetes,myocardial infarction (type 1),Increase,6.0,06,Final
,diabetes,FIRST ISCHEMIC STROKE,Increase,4.52,06,Final
,diabetes,BMI,Increase,4.52,06,Final
,diabetes,cardiac autonomic dysbalance,Increase,4.0,06,Final
,dissection,FIRST ISCHEMIC STROKE,Increase,3.92,06,Final
,dysphagia,infection,Increase,3.22,06,Final
,elevated catecholamines,severe arrrhythmia,Increase,3.76,06,Final
Ghadri 2018,elevated catecholamines,Takotsubo syndrome,Increase,6.0,06,Final
,exercise (cardiac not excessive),hypertension,Decrease,3.92,06,Final
Diener 2020,exercise (cardiac not excessive),FIRST ISCHEMIC STROKE,Decrease,4.0,06,Final
Strohle et al 2015,exercise (cardiac not excessive),kognitive decline,Decrease,3.0,06,Final
,exercise (cardiac not excessive),atrial fibrillation,Increase,2.52,06,Final
,exercise (cardiac not excessive),myocardial infarction (type 1),Decrease,2.72,06,Final
,exercise (cardiac not excessive),chronic heart failure,Decrease,3.92,06,Final
Scheitz et al 2014,FIRST ISCHEMIC STROKE,troponin elevation,Increase,6.0,06,Final
,FIRST ISCHEMIC STROKE,second ischemic stroke,Increase,6.84,06,Final
Diener 2020,FIRST ISCHEMIC STROKE,mortality,Increase,6.0,06,Final
scheitz 2018,FIRST ISCHEMIC STROKE,acute heart failure,Increase,3.0,06,Final
,FIRST ISCHEMIC STROKE,higher fitness/mobility post,Decrease,4.34,06,Final
,FIRST ISCHEMIC STROKE,kognitive decline,Increase,4.52,06,Final
Thygesen 2018,FIRST ISCHEMIC STROKE,myocardial infarction (type 2),Increase,6.0,06,Final
,FIRST ISCHEMIC STROKE,depression,Increase,4.61,06,Final
"Scheitz, Templin 2021 under review",FIRST ISCHEMIC STROKE,Takotsubo syndrome,Increase,3.0,06,Final
,FIRST ISCHEMIC STROKE,infection,Increase,3.22,06,Final
"Scheitz et al, Sposato 2020",FIRST ISCHEMIC STROKE,elevated catecholamines,Increase,2.0,06,Final
,FIRST ISCHEMIC STROKE,seizures,Increase,4.17,06,Final
,FIRST ISCHEMIC STROKE,dysphagia,Increase,3.22,06,Final
scheitz et al 2018,FIRST ISCHEMIC STROKE,severe arrrhythmia,Increase,6.0,06,Final
,higher fitness/mobility post,second ischemic stroke,Increase,4.34,06,Final
,higher fitness/mobility pre,FIRST ISCHEMIC STROKE,Decrease,4.34,06,Final
,higher fitness/mobility pre,mortality,Decrease,6.0,06,Final
,hyperlipidemia,myocardial infarction (type 1),Increase,6.84,06,Final
,hyperlipidemia,FIRST ISCHEMIC STROKE,Increase,3.22,06,Final
,hypertension,myocardial infarction (type 1),Increase,6.84,06,Final
,hypertension,FIRST ISCHEMIC STROKE,Increase,5.1,06,Final
,hypertension,dissection,Increase,3.92,06,Final
,hypertension,chronic heart failure,Increase,5.1,06,Final
Sandoval 2019,hypertension,myocardial infarction (type 2),Increase,4.0,06,Final
,hypertension,acute heart failure,Increase,5.1,06,Final
,infection,mortality,Increase,3.22,06,Final
Sandoval 2019,infection,myocardial infarction (type 2),Increase,4.0,06,Final
van der Linden 2017,kidney disease,troponin elevation,Increase,2.0,06,Final
,myocardial infarction (type 1),FIRST ISCHEMIC STROKE,Increase,2.68,06,Final
Rizas et al 2017,myocardial infarction (type 1),cardiac autonomic dysbalance,Increase,6.0,06,Final
"thygesen et al 2018, McAloon 2016",myocardial infarction (type 1),mortality,Increase,6.0,06,Final
thygesen et al 2018,myocardial infarction (type 1),severe arrrhythmia,Increase,6.0,06,Final
thygesen et al 2018,myocardial infarction (type 1),troponin elevation,Increase,6.0,06,Final
Thygesen 2018,myocardial infarction (type 1),acute heart failure,Increase,6.0,06,Final
Thygesen 2018,myocardial infarction (type 1),cardiac thrombus,Increase,5.0,06,Final
,myocardial infarction (type 1),chronic heart failure,Increase,6.84,06,Final
DeFilippis 2019,myocardial infarction (type 2),troponin elevation,Increase,6.0,06,Final
McCarthy et al 2018,myocardial infarction (type 2),mortality,Increase,6.0,06,Final
Wiktor 2018,persistent foramen ovale,FIRST ISCHEMIC STROKE,Increase,3.0,06,Final
,second ischemic stroke,mortality,Increase,6.0,06,Final
,seizures,mortality,Increase,6.54,06,Final
Faria et al 2020,seizures,troponin elevation,Increase,4.0,06,Final
,severe arrrhythmia,mortality,Increase,6.68,06,Final
,sex (male),smoking,Increase,3.84,06,Final
,sex (male),FIRST ISCHEMIC STROKE,Increase,4.34,06,Final
,sex (male),Takotsubo syndrome,Decrease,2.68,06,Final
,smoking,FIRST ISCHEMIC STROKE,Increase,6.84,06,Final
,smoking,myocardial infarction (type 1),Increase,6.84,06,Final
,stroke lesion affecting central autonomic network,cardiac autonomic dysbalance,Increase,2.72,06,Final
Scheitz et.al 2018 lancet,stroke lesion affecting central autonomic network,severe arrrhythmia,Increase,6.0,06,Final
Krause et al 2017,stroke lesion affecting central autonomic network,troponin elevation,Increase,6.0,06,Final
Scheitz 2018,stroke lesion affecting central autonomic network,elevated catecholamines,Increase,2.0,06,Final
Ghadri et at 2018,Takotsubo syndrome,troponin elevation,Increase,4.0,06,Final
scheitz 2014,troponin elevation,higher fitness/mobility post,Decrease,3.0,06,Final
broersen et al 2020,troponin elevation,kognitive decline,Increase,4.0,06,Final
,age,first-ever ischemic stroke occurence,Increase,6.84,07,Final
,sex (being male),first-ever ischemic stroke occurence,Increase,6.84,07,Final
,BMI,first-ever ischemic stroke occurence,Increase,6.84,07,Final
Gorelick et al (1997),LDL-cholesterol,first-ever ischemic stroke occurence,Increase,6.0,07,Final
MacMahon et al (1990),blood pressure,first-ever ischemic stroke occurence,Increase,6.0,07,Final
,BMI,LDL-cholesterol,Increase,6.84,07,Final
,BMI,blood pressure,Increase,6.84,07,Final
,LDL-cholesterol,atherosclerosis (measured by low ABI),Increase,6.84,07,Final
,atrial fibrilation,first-ever ischemic stroke occurence,Increase,6.84,07,Final
,occurence of myocardial infarction,first-ever ischemic stroke occurence,Increase,4.17,07,Final
Shinton et al (1999),smoking,first-ever ischemic stroke occurence,Increase,6.0,07,Final
Wilhelmsson et al (1975),smoking,occurence of myocardial infarction,Increase,6.0,07,Final
,smoking,blood pressure,Increase,6.84,07,Final
,smoking,atherosclerosis (measured by low ABI),Increase,6.84,07,Final
,first-ever ischemic stroke occurence,second ischemic stroke occurence,Increase,6.84,07,Final
,LDL-cholesterol,second ischemic stroke occurence,Increase,6.84,07,Final
,LDL-cholesterol,second ischemic stroke occurence,Increase,2.58,07,Final
,age,second ischemic stroke occurence,Increase,2.68,07,Final
,BMI,second ischemic stroke occurence,Increase,2.68,07,Final
,atherosclerosis (measured by low ABI),second ischemic stroke occurence,Increase,2.68,07,Final
,atrial fibrilation,second ischemic stroke occurence,Increase,2.68,07,Final
,occurence of myocardial infarction,second ischemic stroke occurence,Increase,2.68,07,Final
,smoking,second ischemic stroke occurence,Increase,2.68,07,Final
,anticoagulation medication,first-ever ischemic stroke occurence,Decrease,2.68,07,Final
Schneider et al. (2004),first-ever ischemic stroke occurence,cognitive function,Decrease,2.0,07,Final
Snowdon et al. (1997),second ischemic stroke occurence,cognitive function,Decrease,2.0,07,Final
Schneider et al. (2014),atherosclerosis (measured by low ABI),cognitive function,Decrease,2.0,07,Final
Guerchet et al (2011),age,cognitive function,Decrease,2.68,07,Final
,diabetes mellitus,first-ever ischemic stroke occurence,Increase,2.0,07,Final
Kannell et al (1979),diabetes mellitus,second ischemic stroke occurence,Increase,2.68,07,Final
,diabetes mellitus,occurence of myocardial infarction,Increase,2.68,07,Final
,diabetes mellitus,atherosclerosis (measured by low ABI),Increase,2.68,07,Final
,sex (being male),atherosclerosis (measured by low ABI),Increase,2.68,07,Final
,BMI,diabetes mellitus,Increase,2.68,07,Final
,age,diabetes mellitus,Increase,2.68,07,Final
,exercise,first-ever ischemic stroke occurence,Decrease,2.68,07,Final
,exercise,BMI,Decrease,2.68,07,Final
,exercise,LDL-cholesterol,Decrease,0.83,07,Final
,exercise,blood pressure,Decrease,3.29,07,Final
,exercise,atherosclerosis (measured by low ABI),Decrease,0.78,07,Final
,exercise,occurence of myocardial infarction,Decrease,3.29,07,Final
,exercise,second ischemic stroke occurence,Decrease,3.29,07,Final
,exercise,diabetes mellitus,Decrease,3.6,07,Final
,infectious endocarditis,first-ever ischemic stroke occurence,Increase,3.6,07,Final
,alcohol consumption,first-ever ischemic stroke occurence,Increase,3.6,07,Final
,alcohol consumption,second ischemic stroke occurence,Increase,1.46,07,Final
,alcohol consumption,blood pressure,Increase,1.46,07,Final
,age,alcohol consumption,Increase,0.89,07,Final
,sex (being male),alcohol consumption,Increase,1.81,07,Final
,stress,first-ever ischemic stroke occurence,Increase,2.58,07,Final
,stress,blood pressure,Increase,2.58,07,Final
,stress,occurence of myocardial infarction,Increase,2.58,07,Final
,stress,smoking,Increase,1.11,07,Final
,stress,second ischemic stroke occurence,Increase,1.11,07,Final
,stress,alcohol consumption,Increase,1.11,07,Final
,stress,atherosclerosis (measured by low ABI),Increase,1.11,07,Final
,diabetes mellitus,cognitive function,Decrease,2.0,07,Final
Knopman et al (2001),statin use,first-ever ischemic stroke occurence,Decrease,1.0,07,Final
Hebert et al (1997),statin use,LDL-cholesterol,Decrease,4.8,07,Final
,statin use,atherosclerosis (measured by low ABI),Decrease,1.4,07,Final
,statin use,occurence of myocardial infarction,Decrease,2.86,07,Final
,Lipoprotein a,first-ever ischemic stroke occurence,Increase,2.0,07,Final
Nave et al (2015),Lipoprotein a,atherosclerosis (measured by low ABI),Increase,2.68,07,Final
,atherosclerosis (measured by low ABI),first-ever ischemic stroke occurence,Increase,5.0,07,Final
Hong et al. (2016),blood pressure,cognitive function,Decrease,2.68,07,Final
Knopman et al (2001),antihypertensive medicatio,first-ever ischemic stroke occurence,Decrease,2.68,07,Final
Collins et al (1990),antihypertensive medicatio,occurence of myocardial infarction,Decrease,2.68,07,Final
Collins et al (1990),BMI,atherosclerosis (measured by low ABI),Increase,2.68,07,Final
McGill et al (2002),BMI,occurence of myocardial infarction,Increase,2.68,07,Final
Burn et al. (1994),first ischemic stroke,second ischemic stroke,Increase,6.84,09,Final
Brønnum-Hansen et al. (2001),first ischemic stroke,mortality,Increase,6.84,09,Final
Hankey et al. (2002),first ischemic stroke,disability,Increase,6.84,09,Final
Davenport et al. (1996),first ischemic stroke,pneumonia,Increase,6.0,09,Final
Johnston et al. (1998),first ischemic stroke,urinary tract infection,Increase,6.0,09,Final
Davenport et al. (1996),pneumonia,mortality,Increase,6.0,09,Final
Finlayson et al. (2011),second ischemic stroke,mortality,Increase,2.68,09,Final
Poisson et al. (2010),second ischemic stroke,disability,Increase,2.68,09,Final
Ersoz et al. (2007),urinary catheter placement,urinary tract infection,Increase,6.0,09,Final
van der Worp & Kappelle (1998),first ischemic stroke,bladder dysfunction,Increase,6.0,09,Final
,first ischemic stroke,urinary catheter placement,Increase,2.0,09,Final
Poisson et al. (2010),bladder dysfunction,urinary tract infection,Increase,2.68,09,Final
,first ischemic stroke,immunosuppression,Increase,0.51,09,Final
Maki & Tambyah (2001),immunosuppression,urinary tract infection,Increase,0.51,09,Final
Gould et al. (2010),sex(female),urinary tract infection,Increase,6.0,09,Final
Kong & Young (2000),age,urinary tract infection,Increase,6.0,09,Final
Poisson et al. (2010),age,first ischemic stroke,Increase,6.0,09,Final
,urinary tract infection,mortality,Increase,0.51,09,Final
Poisson et al. (2010),urinary tract infection,disability,Increase,0.51,09,Final
Poisson et al. (2010),first ischemic stroke,body temperature,Increase,0.51,09,Final
Azzimondi et al. (1995),urinary tract infection,body temperature,Increase,6.84,09,Final
Boysen & Christensen (2001),pneumonia,body temperature,Increase,6.84,09,Final
,body temperature,mortality,Increase,0.51,09,Final
,body temperature,disability,Increase,0.51,09,Final
Jauch et al. (2013),first ischemic stroke,delirium,Increase,0.51,09,Final
Jauch et al. (2013),age,delirium,Increase,6.84,09,Final
Oldenbeuving et al. (2007),urinary tract infection,delirium,Increase,0.51,09,Final
Oldenbeuving et al. (2007),pneumonia,delirium,Increase,0.51,09,Final
Oldenbeuving et al. (2007),delirium,disability,Increase,0.51,09,Final
Oldenbeuving et al. (2007),stroke unit care,delirium,Decrease,0.51,09,Final
Oldenbeuving et al. (2007),bladder dysfunction,urinary catheter placement,Increase,0.51,09,Final
Oldenbeuving et al. (2007),age,pneumonia,Increase,2.68,09,Final
,pneumonia,disability,Increase,0.51,09,Final
Finlayson et al. (2011),first ischemic stroke,dysphagia,Increase,6.0,09,Final
Finlayson et al. (2011),dysphagia,pneumonia,Increase,6.84,09,Final
Martino et al. (2005),dysphagia,aspiration,Increase,6.84,09,Final
Martino et al. (2005),aspiration,pneumonia,Increase,6.84,09,Final
Martino et al. (2005),smoking,first ischemic stroke,Increase,6.84,09,Final
Martino et al. (2005),smoking,second ischemic stroke,Increase,6.84,09,Final
,sex(male),first ischemic stroke,Increase,6.84,09,Final
,atrial fibrillation,first ischemic stroke,Increase,6.84,09,Final
,BMI,first ischemic stroke,Increase,6.84,09,Final
,atrial fibrillation,second ischemic stroke,Increase,6.84,09,Final
,BMI,second ischemic stroke,Increase,6.84,09,Final
,blood pressure,first ischemic stroke,Increase,6.84,09,Final
,blood pressure,second ischemic stroke,Increase,6.84,09,Final
,age,blood pressure,Increase,6.84,09,Final
,age,smoking,Decrease,2.93,09,Final
,first ischemic stroke,stroke unit care,Increase,6.84,09,Final
,blood lipids,first ischemic stroke,Increase,6.84,09,Final
Jauch et al. (2013),diabetes,first ischemic stroke,Increase,6.84,09,Final
,first ischemic stroke,blood glucose,Increase,6.0,09,Final
Khoury et al. (2013),diabetes,blood glucose,Increase,6.0,09,Final
Jauch et al. (2013),age,diabetes,Increase,2.68,09,Final
,BMI,diabetes,Increase,2.68,09,Final
,sex(male),smoking,Increase,2.68,09,Final
Langhorne et al. (2020),stroke unit care,mortality,Decrease,4.71,09,Final
Langhorne et al. (2020),stroke unit care,disability,Decrease,4.17,09,Final
Touzé et al. (2005),first ischemic stroke,myocardial infarction,Increase,1.0,09,Final
,myocardial infarction,mortality,Increase,6.0,09,Final
Sulter et al. (2000),first ischemic stroke,oxygen saturation,Decrease,5.0,09,Final
Rowat et al. (2006),patient positioning,oxygen saturation,Increase,0.51,09,Final
Rowat et al. (2001),pneumonia,oxygen saturation,Decrease,6.84,09,Final
,age,oxygen saturation,Decrease,0.51,09,Final
Sulter et al. (2000),dysphagia,oxygen saturation,Decrease,0.51,09,Final
Sulter et al. (2000),oxygen saturation,mortality,Decrease,0.51,09,Final
Rowat et al. (2006),first ischemic stroke,dependency,Increase,6.0,09,Final
,disability,dependency,Increase,6.0,09,Final
,dysphagia,dependency,Increase,2.68,09,Final
Martino et al. (2005),first ischemic stroke,urinary incontinence,Increase,2.68,09,Final
Nakayama et al. (1997),age,urinary incontinence,Increase,2.68,09,Final
Nakayama et al. (1997),urinary incontinence,dependency,Increase,2.68,09,Final
Patel et al. (2001),diabetes,urinary incontinence,Increase,0.51,09,Final
,urinary incontinence,urinary catheter placement,Increase,0.51,09,Final
,first ischemic stroke,paralysis,Increase,6.84,09,Final
,paralysis,disability,Increase,6.84,09,Final
,paralysis,dependency,Increase,6.84,09,Final
,first ischemic stroke,deep vein thrombosis,Increase,6.84,09,Final
Kappelle et al. (2011),paralysis,deep vein thrombosis,Increase,6.84,09,Final
Kappelle et al. (2011),deep vein thrombosis,pulmonary embolism,Increase,6.84,09,Final
,pulmonary embolism,mortality,Increase,6.84,09,Final
,pulmonary embolism,oxygen saturation,Decrease,6.84,09,Final
,paralysis,pneumonia,Increase,2.0,09,Final
,first ischemic stroke,falls,Increase,6.0,09,Final
Wei et al. (2019),age,falls,Increase,2.68,09,Final
,urinary incontinence,falls,Increase,2.68,09,Final
,delirium,falls,Increase,2.68,09,Final
,falls,fractures,Increase,2.0,09,Final
Melton et al. (2001),first ischemic stroke,fractures,Increase,2.68,09,Final
Kanis et al. (2001),fractures,disability,Increase,0.51,09,Final
,fractures,dependency,Increase,0.51,09,Final
,physical activity,first ischemic stroke,Increase,6.84,09,Final
low or very high,alcohol consumption,first ischemic stroke,Increase,3.84,09,Final
,atherosclerosis,first ischemic stroke,Increase,6.0,09,Final
,blood lipids,second ischemic stroke,Increase,6.0,09,Final
,alcohol consumption,second ischemic stroke,Increase,3.0,09,Final
,physical activity,second ischemic stroke,Increase,6.0,09,Final
,education,first ischemic stroke,Decrease,1.0,09,Final
Reshetnyak et al. (2020),income,first ischemic stroke,Decrease,1.0,09,Final
Reshetnyak et al. (2020),social isolation,first ischemic stroke,Increase,0.51,09,Final
Reshetnyak et al. (2020),TIA,first ischemic stroke,Increase,6.84,09,Final
O'Donnell et al. 2016,Smoking,first ischemic stroke,Increase,6.84,10,Final
O'Donnell et al. 2016,Diabetes mellitus,first ischemic stroke,Increase,6.84,10,Final
O'Donnell et al. 2016,moderate physical activity,first ischemic stroke,Decrease,6.84,10,Final
,moderate physical activity,Diabetes mellitus,Decrease,6.84,10,Final
"O'Donnell et al. 2016, Paterson et al. 2018",healthy (mediterranean) diet,first ischemic stroke,Decrease,6.84,10,Final
,healthy (mediterranean) diet,Diabetes mellitus,Decrease,3.92,10,Final
"Ebrahim et al., 2006",hyperlipoproteinemia (high LDL),first ischemic stroke,Increase,6.0,10,Final
,atrial fibrillation,first ischemic stroke,Increase,6.84,10,Final
,dissection of cerebral vessel,first ischemic stroke,Increase,6.84,10,Final
,atherosclerosis,first ischemic stroke,Increase,6.84,10,Final
,hyperlipoproteinemia (high LDL),atherosclerosis,Increase,6.84,10,Final
,positive familiy history of cardio/cerebrovascular events,first ischemic stroke,Increase,6.84,10,Final
,stenoses of cerebral vessels,first ischemic stroke,Increase,4.17,10,Final
,atherosclerosis,stenoses of cerebral vessels,Increase,6.84,10,Final
,dissection of cerebral vessel,stenoses of cerebral vessels,Increase,6.84,10,Final
In patients where no other risk factors are found and the PFO shows a right-->left shunt and shows a hypermobile septum,patent foramen ovale (PFO),first ischemic stroke,Increase,3.52,10,Final
Bushnell at el. 2014,oral contraceptives,first ischemic stroke,Increase,3.0,10,Final
in women with other cardiovascular risk factors or vessels that are sensitive to homonal changes,depression,first ischemic stroke,Increase,3.0,10,Final
"O'Donnell et al., 2010",antidepressive medication,first ischemic stroke,Increase,3.52,10,Final
,depression,antidepressive medication,Increase,3.52,10,Final
,antiplatelet therapy (e.g. ASS),first ischemic stroke,Decrease,6.0,10,Final
In patients with high cardiovascular risk profile,Statins,first ischemic stroke,Decrease,6.84,10,Final
"In patients with high cardiovascular risk profile, especially high LDL-Cholesterine",Statins,hyperlipoproteinemia (high LDL),Decrease,6.0,10,Final
"Law et al., 2003",first ischemic stroke,second ischemic stroke,Increase,6.0,10,Final
"Khanevski et al., 2019",age,hyperlipoproteinemia (high LDL),Increase,4.34,10,Final
,age,atrial fibrillation,Increase,6.84,10,Final
,age,patent foramen ovale (PFO),Decrease,3.68,10,Final
,age,first ischemic stroke,Increase,6.84,10,Final
,arterial hypertension,first ischemic stroke,Increase,6.84,10,Final
O'Donnell et al 2016,age,death (all causes),Increase,6.0,10,Final
,age,arterial hypertension,Increase,6.84,10,Final
,age,second ischemic stroke,Increase,6.0,10,Final
"Khanevski et al., 2019",Smoking,second ischemic stroke,Increase,6.84,10,Final
,Diabetes mellitus,second ischemic stroke,Increase,6.84,10,Final
,hyperlipoproteinemia (high LDL),second ischemic stroke,Increase,6.84,10,Final
,moderate physical activity,second ischemic stroke,Decrease,6.84,10,Final
,healthy (mediterranean) diet,second ischemic stroke,Decrease,6.84,10,Final
,atrial fibrillation,second ischemic stroke,Increase,6.84,10,Final
,dissection of cerebral vessel,second ischemic stroke,Increase,6.84,10,Final
,atherosclerosis,second ischemic stroke,Increase,6.84,10,Final
,positive familiy history of cardio/cerebrovascular events,second ischemic stroke,Increase,3.6,10,Final
,stenoses of cerebral vessels,second ischemic stroke,Increase,3.6,10,Final
,antiplatelet therapy (e.g. ASS),second ischemic stroke,Decrease,6.0,10,Final
Kernan et al. 2014,Statins,second ischemic stroke,Decrease,6.0,10,Final
"Amarenco et al., 2020",first ischemic stroke,post stroke epilepsy,Increase,5.31,10,Final
Browne and Holmes 2001,second ischemic stroke,post stroke epilepsy,Increase,6.84,10,Final
Browne and Holmes 2001,stroke severity (e.g. measured by NIHSS),post stroke epilepsy,Increase,6.0,10,Final
"Slapo et al., 2006",post stroke epilepsy,functional outcome (e.g. measured by mRS),Increase,4.0,10,Final
Arntz et al. 2013,stroke severity (e.g. measured by NIHSS),functional outcome (e.g. measured by mRS),Increase,4.26,10,Final
Arntz et al. 2013,obesity,first ischemic stroke,Increase,5.76,10,Final
,obesity,second ischemic stroke,Increase,5.76,10,Final
"Kernan et al., 2014 (AHA/ASA Guideline)",sleep apnea,first ischemic stroke,Increase,5.76,10,Final
"Kernan et al., 2014 (AHA/ASA Guideline)",sleep apnea,second ischemic stroke,Increase,5.76,10,Final
"Kernan et al., 2014 (AHA/ASA Guideline)",obesity,sleep apnea,Increase,3.29,10,Final
"Kernan et al., 2014 (AHA/ASA Guideline)",anticoagulation,first ischemic stroke,Decrease,6.84,10,Final
,anticoagulation,second ischemic stroke,Decrease,6.84,10,Final
Kernan et al. 2014 (for some patients patients with atrial fibrillation and some patients with thrombophilia),low socioeconomic status,death (all causes),Increase,4.43,10,Final
Kernan et al. 2014 (for patients patients with atrial fibrillation and some patients with thrombophilia),post stroke epilepsy,death (all causes),Increase,6.26,10,Final
"Vivanco-Hidalgo et al., 2019",arterial hypertension,second ischemic stroke,Increase,6.0,10,Final
Arrich et al. 2005,arterial hypertension,atherosclerosis,Increase,5.53,10,Final
Burneo et al. 2009,female sex,oral contraceptives,Increase,4.52,10,Final
"Khanevsky et al., 2019",female sex,depression,Increase,4.52,10,Final
,female sex,first ischemic stroke,Decrease,4.43,10,Final
,female sex,second ischemic stroke,Decrease,4.43,10,Final
Bushnell et al. 2014,female sex,migraine with aura,Increase,4.43,10,Final
Bushnell et al. 2014,migraine with aura,first ischemic stroke,Increase,4.43,10,Final
Bushnell et al. 2014,migraine with aura,second ischemic stroke,Increase,3.84,10,Final
Bushnell et al. 2014,female sex,arterial hypertension,Increase,3.84,10,Final
Bushnell et al. 2014,oral contraceptives,second ischemic stroke,Increase,4.08,10,Final
Bushnell et al. 2014,"preeclampsia and other pregancy related complications (e.g. arterial hypertension, diabetes)",second ischemic stroke,Increase,4.08,10,Final
Bushnell et al. 2014,"preeclampsia and other pregancy related complications (e.g. arterial hypertension, diabetes)",first ischemic stroke,Increase,4.08,10,Final
Bushnell et al. 2014,"preeclampsia and other pregancy related complications (e.g. arterial hypertension, diabetes)",arterial hypertension,Increase,4.08,10,Final
Bushnell et al. 2014,"preeclampsia and other pregancy related complications (e.g. arterial hypertension, diabetes)",Diabetes mellitus,Increase,4.08,10,Final
Bushnell et al. 2014,female sex,"preeclampsia and other pregancy related complications (e.g. arterial hypertension, diabetes)",Increase,6.84,10,Final
Bushnell et al. 2014,moderate physical activity,obesity,Decrease,6.84,10,Final
Bushnell et al. 2014,healthy (mediterranean) diet,obesity,Decrease,6.84,10,Final
Bushnell et al. 2014,stroke severity (e.g. measured by NIHSS),death (all causes),Increase,6.84,10,Final
,first ischemic stroke,death (all causes),Increase,6.26,10,Final
,second ischemic stroke,death (all causes),Increase,6.26,10,Final
,depression,death (all causes),Increase,5.53,10,Final
"Khanevski et al., 2019",moderate physical activity,migraine with aura,Decrease,4.17,10,Final
"Khanevski et al., 2019",healthy (mediterranean) diet,death (all causes),Decrease,5.42,10,Final
,obesity,death (all causes),Increase,5.42,10,Final
,Smoking,death (all causes),Increase,5.42,10,Final
"Bushnell et al., 2014",moderate physical activity,death (all causes),Decrease,5.42,10,Final
"Bushnell et al., 2014",atrial fibrillation,death (all causes),Increase,5.42,10,Final
"Bushnell et al., 2014",atrial fibrillation,stroke severity (e.g. measured by NIHSS),Increase,6.84,10,Final
"Bushnell et al., 2014",atrial fibrillation,anticoagulation,Increase,6.84,10,Final
"Goldstein et al., 2011",atherosclerosis,antiplatelet therapy (e.g. ASS),Increase,6.84,10,Final
"Goldstein et al., 2011",stenoses of cerebral vessels,antiplatelet therapy (e.g. ASS),Increase,6.84,10,Final
,Smoking,atherosclerosis,Increase,6.84,10,Final
,Smoking,stenoses of cerebral vessels,Increase,6.84,10,Final
,sleep apnea,arterial hypertension,Increase,4.52,10,Final
,Diabetes mellitus,arterial hypertension,Increase,4.52,10,Final
,low socioeconomic status,Smoking,Increase,4.0,10,Final
,low socioeconomic status,arterial hypertension,Increase,4.08,10,Final
,low socioeconomic status,healthy (mediterranean) diet,Decrease,4.08,10,Final
Marshall et al. 2015,low socioeconomic status,moderate physical activity,Decrease,4.08,10,Final
Marshall et al. 2015,low socioeconomic status,first ischemic stroke,Increase,4.08,10,Final
Marshall et al. 2015,low socioeconomic status,second ischemic stroke,Increase,4.08,10,Final
Marshall et al. 2015,low socioeconomic status,depression,Increase,5.53,10,Final
Marshall et al. 2015,cortical involvement or strategical localisation of stroke lesion,functional outcome (e.g. measured by mRS),Increase,5.53,10,Final
Marshall et al. 2015,cortical involvement or strategical localisation of stroke lesion,post stroke epilepsy,Increase,5.53,10,Final
Lorant et al. 2013,second ischemic stroke,functional outcome (e.g. measured by mRS),Increase,5.0,10,Final
"Asplund et al, Stroke 2009",age,first ischemic stroke,Increase,6.0,11,Final
40:2319-2326,male sex,first ischemic stroke,Increase,5.0,11,Final
"Bushnell et al., JCBF2018",hypertension,first ischemic stroke,Increase,5.0,11,Final
38: 2179–2191)postmenopausal vs premenopausal,metabolic syndrom,first ischemic stroke,Increase,6.0,11,Final
"Cipolla et al., JCBF2018",inflammation,first ischemic stroke,Increase,6.0,11,Final
38:2129-2149,inflammation,blood-brain barrier breakdown,Increase,6.0,11,Final
"includes diabetes, hyperlipoproteinemia, obesity (Sol M Rodriguez-Colon, stroke 2009",blood-brain barrier breakdown,first ischemic stroke,Increase,6.0,11,Final
40:200-205),metabolic syndrom,white matter hyperintensities (MRI),Increase,6.0,11,Final
"Bernardo-Castro et al., Front Neurol 2020",white matter hyperintensities (MRI),first ischemic stroke,Increase,6.0,11,Final
doi: 10.3389/fneur.2020.594672,exercise,first ischemic stroke,Decrease,0.51,11,Final
"Bernardo-Castro et al., Front Neurol 2020",exercise,metabolic syndrom,Decrease,0.51,11,Final
doi: 10.3389/fneur.2020.594672,exercise,hypertension,Decrease,0.51,11,Final
"Bernardo-Catro et al., 2020",hypertension,white matter hyperintensities (MRI),Increase,4.8,11,Final
"Frey et al, Front Neurol 2019",smoking,first ischemic stroke,Increase,5.31,11,Final
doi: 10.3389/fneur.2019.00238,smoking,white matter hyperintensities (MRI),Increase,5.0,11,Final
"Ryu et al., Brain 2017 doi: 10.1093/brain/aww259",atherosclerosis,white matter hyperintensities (MRI),Increase,6.0,11,Final
,metabolic syndrom,atherosclerosis,Increase,6.0,11,Final
,atherosclerosis/thrombosis,first ischemic stroke,Increase,6.0,11,Final
,cardiac dysfunction,first ischemic stroke,Increase,6.0,11,Final
120 versus 135 systolic blood pressure,cardiac dysfunction,white matter hyperintensities (MRI),Increase,6.54,11,Final
,atherosclerosis,vessel stenosis/occlusion,Increase,6.0,11,Final
"Power et al., Neurology 2015",vessel stenosis/occlusion,white matter hyperintensities (MRI),Increase,6.13,11,Final
84:841-848,vessel stenosis/occlusion,first ischemic stroke,Increase,6.0,11,Final
,atherosclerosis,vulnerable plaques,Increase,3.0,11,Final
"Sun et al., Sci Rep 2016 doi: 10.1038/srep33246",vulnerable plaques,first ischemic stroke,Increase,6.0,11,Final
"Famakin et al., Stroke 2009 doi: 10.1161/STROKEAHA.108.546150",vulnerable plaques,white matter hyperintensities (MRI),Increase,6.84,11,Final
"myocardial infarction, coronary heart disease, cardiac failure Folsom et al., Stroke 2013",endarterectomy,vulnerable plaques,Decrease,1.0,11,Final
44:961-967,endarterectomy,vessel stenosis/occlusion,Decrease,2.0,11,Final
"myocardial infarction, coronary heart disease, cardiac failure",kidney function,first ischemic stroke,Increase,3.0,11,Final
"Hoshino et al., Jama Neurol 2018 doi: 10.1001/jamaneurol.2017.3960",kidney function,white matter hyperintensities (MRI),Increase,5.0,11,Final
,metabolic syndrom,kidney function,Increase,6.0,11,Final
"Adams et al., Stroke 1993",enlarged perivascular spaces,first ischemic stroke,Increase,4.0,11,Final
24:35-41,microbleeds,white matter hyperintensities (MRI),Increase,6.0,11,Final
,preeclampsia/eclampsia,first ischemic stroke,Increase,6.84,11,Final
"Kassem et al., Ann Transl Med 2020 doi: 10.21037/atm-2020-cass-16",race,first ischemic stroke,Increase,6.68,11,Final
,preeclampsia/eclampsia,hypertension,Increase,6.0,11,Final
"Cochrane Database Syst Rev. 2020, doi: 10.1002/14651858.CD000515.pub",genetic factors,first ischemic stroke,Increase,5.53,11,Final
,inflammation,white matter hyperintensities (MRI),Increase,6.13,11,Final
"Kelley et al., Stroke 2020 doi: 10.1161/STROKEAHA.120.030045",infection,first ischemic stroke,Increase,5.2,11,Final
"Kim et al., Sci Rep 2019 doi: 10.1038/s41598-019-45109-y",infection,inflammation,Increase,5.42,11,Final
,inflammation,coagulopathy,Increase,5.42,11,Final
"Ballerini et al., Neuroimage Clin 2020 doi: 10.1016/j.nicl.2019.102120",coagulopathy,first ischemic stroke,Increase,6.84,11,Final
,first ischemic stroke,second ischemic stroke,Increase,6.39,13,Draft
,atherosclerosis,first ischemic stroke,Increase,5.0,13,Draft
,atherosclerosis,second ischemic stroke,Increase,5.0,13,Draft
,atrial fibrillation,second ischemic stroke,Increase,4.26,13,Draft
,atrial fibrillation,first ischemic stroke,Increase,4.26,13,Draft
,cancer,first ischemic stroke,Increase,4.08,13,Draft
,vaskulitis,first ischemic stroke,Increase,5.2,13,Draft
,vaskulitis,second ischemic stroke,Increase,5.2,13,Draft
,cancer,second ischemic stroke,Increase,5.2,13,Draft
,chemotherapy,first ischemic stroke,Increase,5.2,13,Draft
,chemotherapy,second ischemic stroke,Increase,5.2,13,Draft
,cancer,chemotherapy,Increase,5.2,13,Draft
,sinus venous thrombosis,first ischemic stroke,Increase,5.2,13,Draft
,sinus venous thrombosis,second ischemic stroke,Increase,5.2,13,Draft
,age,second ischemic stroke,Increase,5.2,13,Draft
,age,first ischemic stroke,Increase,5.2,13,Draft
,age,atherosclerosis,Increase,5.2,13,Draft
,smoking,atherosclerosis,Increase,5.2,13,Draft
,smoking,first ischemic stroke,Increase,5.2,13,Draft
,smoking,second ischemic stroke,Increase,5.2,13,Draft
,dyslipidemia,second ischemic stroke,Increase,5.2,13,Draft
,dyslipidemia,first ischemic stroke,Increase,5.2,13,Draft
,dyslipidemia,atherosclerosis,Increase,5.2,13,Draft
,diabetes,atherosclerosis,Increase,5.2,13,Draft
,diabetes,first ischemic stroke,Increase,5.2,13,Draft
,diabetes,second ischemic stroke,Increase,5.2,13,Draft
,age,atrial fibrillation,Increase,4.08,13,Draft
,age,cancer,Increase,4.08,13,Draft
,female gender,sinus venous thrombosis,Increase,4.08,13,Draft
,male gender,first ischemic stroke,Increase,4.08,13,Draft
,male gender,second ischemic stroke,Increase,4.08,13,Draft
,pregnancy,sinus venous thrombosis,Increase,4.08,13,Draft
,female gender,pregnancy,Increase,6.84,13,Draft
,first ischemic stroke,disability,Increase,6.84,13,Draft
,second ischemic stroke,disability,Increase,6.84,13,Draft
,cancer,disability,Increase,6.84,13,Draft
,vaskulitis,disability,Increase,6.84,13,Draft
,diabetes,disability,Increase,6.84,13,Draft
,arterial hypertension,atherosclerosis,Increase,5.1,13,Draft
,arterial hypertension,first ischemic stroke,Increase,5.1,13,Draft
,arterial hypertension,second ischemic stroke,Increase,5.1,13,Draft
,arterial hypertension,disability,Increase,5.1,13,Draft
,age,arterial hypertension,Increase,5.1,13,Draft
,smoking,arterial hypertension,Increase,5.1,13,Draft
,pregnancy,diabetes,Increase,5.1,13,Draft
,first ischemic stroke,depression,Increase,5.1,13,Draft
,second ischemic stroke,depression,Increase,5.1,13,Draft
,cancer,depression,Increase,5.1,13,Draft
,first ischemic stroke,cognitive decline,Increase,5.1,13,Draft
,second ischemic stroke,cognitive decline,Increase,5.1,13,Draft
,second ischemic stroke,qualitiy of life,Decrease,5.1,13,Draft
,first ischemic stroke,qualitiy of life,Decrease,5.1,13,Draft
,depression,qualitiy of life,Decrease,5.1,13,Draft
,diabetes,qualitiy of life,Decrease,5.1,13,Draft
,vaskulitis,qualitiy of life,Decrease,5.1,13,Draft
,disability,qualitiy of life,Decrease,5.1,13,Draft
,pregnancy,depression,Increase,5.1,13,Draft
,first ischemic stroke,mobility,Decrease,5.1,13,Draft
,second ischemic stroke,mobility,Decrease,2.65,13,Draft
,disability,mobility,Decrease,2.65,13,Draft
,depression,mobility,Decrease,2.65,13,Draft
,cancer,qualitiy of life,Decrease,2.65,13,Draft
,age,mobility,Decrease,3.0,13,Draft
,pregnancy,mobility,Decrease,0.57,13,Draft
,endocarditis,first ischemic stroke,Increase,0.57,13,Draft
,endocarditis,second ischemic stroke,Increase,0.57,13,Draft
,endocarditis,second ischemic stroke,Increase,5.1,13,Draft
,endocarditis,disability,Increase,5.1,13,Draft
,persistent foramen ovale,first ischemic stroke,Increase,5.64,13,Draft
,persistent foramen ovale,second ischemic stroke,Increase,5.64,13,Draft
,hypercoagulability,first ischemic stroke,Increase,4.61,13,Draft
,hypercoagulability,second ischemic stroke,Increase,4.61,13,Draft
,hypercoagulability,sinus venous thrombosis,Increase,4.61,13,Draft
,cancer,hypercoagulability,Increase,4.61,13,Draft
,pregnancy,hypercoagulability,Increase,4.61,13,Draft
,smoking,hypercoagulability,Increase,3.0,13,Draft
,malformations,first ischemic stroke,Increase,1.4,13,Draft
,malformations,second ischemic stroke,Increase,1.4,13,Draft
,endovascular interventions,first ischemic stroke,Increase,5.88,13,Draft
,endovascular interventions,second ischemic stroke,Increase,5.88,13,Draft
,atherosclerosis,endovascular interventions,Increase,5.88,13,Draft
,endocarditis,endovascular interventions,Increase,1.69,13,Draft
,pregnancy,chemotherapy,Decrease,3.14,13,Draft
,neurosurgery,first ischemic stroke,Increase,3.14,13,Draft
,neurosurgery,second ischemic stroke,Increase,4.34,13,Draft
,cancer,neurosurgery,Increase,4.34,13,Draft
,malformations,neurosurgery,Increase,3.14,13,Draft
,migraine,ischemic stroke,Increase,4.17,14,Draft
,migraine,smoking,Decrease,4.52,14,Draft
,obesity,ischemic stroke,Increase,6.0,14,Draft
,hypertension,large artery atherosclerosis,Increase,6.0,14,Draft
,obesity,hypertension,Increase,6.84,14,Draft
,low blood pressure,decreased systemic perfusion,Increase,6.84,14,Draft
,heart failure,decreased systemic perfusion,Increase,6.84,14,Draft
,loss of blood,decreased systemic perfusion,Increase,6.84,14,Draft
,reduction or complete blockage of blood flow,ischemic stroke,Increase,6.84,14,Draft
,decreased systemic perfusion,reduction or complete blockage of blood flow,Increase,6.84,14,Draft
,severe stenosis,reduction or complete blockage of blood flow,Increase,6.84,14,Draft
,occlusion of a blood vessel,reduction or complete blockage of blood flow,Increase,6.84,14,Draft
,arterial dissection,ischemic stroke,Increase,6.84,14,Draft
,COVID-19,ischemic stroke,Increase,6.84,14,Draft
,fibromuscular dysplasia,ischemic stroke,Increase,6.84,14,Draft
,vasculitis,ischemic stroke,Increase,6.84,14,Draft
,Moyamoya disease,ischemic stroke,Increase,6.84,14,Draft
,sickle cell disease arteriopathy,ischemic stroke,Increase,6.84,14,Draft
,ischemic stroke,production of reactive oxygen species,Increase,6.84,14,Draft
,production of reactive oxygen species,DNA damage,Increase,6.84,14,Draft
,ischemic stroke,loss of brain structural integrity,Increase,6.84,14,Draft
,female sex steroids,migraine,Increase,6.84,14,Draft
,female sex steroids,COVID-19,Decrease,3.37,14,Draft
,large artery atherosclerosis,ischemic stroke,Increase,6.84,14,Draft
,ageing,DNA damage,Increase,6.84,14,Draft
,ageing,migraine,Decrease,6.84,14,Draft
,ageing,hypertension,Increase,6.84,14,Draft
,production of reactive oxygen species,endothelial dysfunction,Increase,6.84,14,Draft
,hypercholesterolemia,endothelial dysfunction,Increase,6.84,14,Draft
,smoking,endothelial dysfunction,Increase,6.84,14,Draft
,diabetes mellitus,endothelial dysfunction,Increase,6.84,14,Draft
,hypertension,endothelial dysfunction,Increase,6.84,14,Draft
"Harrison Internal Med., 2020",Embolism,First Ischemic Stroke,Increase,6.0,16,Final
"Harrison Internal Med., 2020",Thrombosis,First Ischemic Stroke,Increase,4.61,16,Final
"Harrison Internal Med., 2020",Lacunes,Thrombosis,Increase,4.61,16,Final
"Harrison Internal Med., 2020",Atrial Fibrillation,Embolism,Increase,4.61,16,Final
"Harrison Internal Med., 2020",Atherosclerosis,Thrombosis,Increase,4.61,16,Final
"Harrison Internal Med., 2020",Male Sex,Atherosclerosis,Increase,4.61,16,Final
"Harrison Internal Med., 2020",Age,Atherosclerosis,Increase,4.61,16,Final
"Harrison Internal Med., 2020",Smoking,Atherosclerosis,Increase,4.61,16,Final
"Harrison Internal Med., 2020",Diabetes,Atherosclerosis,Increase,4.61,16,Final
"Harrison Internal Med., 2020",Dyslipidemia,Atherosclerosis,Increase,4.0,16,Final
"Harrison Internal Med., 2020",Hypertension,Atherosclerosis,Increase,4.61,16,Final
"Harrison Internal Med., 2020",Arterial Dissection,First Ischemic Stroke,Increase,4.61,16,Final
"Harrison Internal Med., 2020",Hypertension,Lacunes,Increase,4.61,16,Final
"Harrison Internal Med., 2020",Age,Lacunes,Increase,4.61,16,Final
"Harrison Internal Med., 2020",Hypercoagulopathy,Thrombosis,Increase,4.61,16,Final
"Harrison Internal Med., 2020",Vasculitis,First Ischemic Stroke,Increase,4.61,16,Final
,Cardiac Remodelling,Atrial Fibrillation,Increase,4.61,16,Final
,Age,Cardiac Remodelling,Increase,4.61,16,Final
,Hypertension,Cardiac Remodelling,Increase,4.61,16,Final
,Atherosclerosis,Cardiac Remodelling,Increase,4.61,16,Final
"Harrison Internal Med., 2020",Atherosclerosis,Myocardial Infarction,Increase,4.61,16,Final
,Myocardial Infarction,Cardiac Remodelling,Increase,4.61,16,Final
"Harrison Internal Med., 2020",Second-hand Smoking,Atherosclerosis,Increase,4.61,16,Final
,Insulin Resistance / Impaired glucose metabolism,Diabetes,Increase,4.0,16,Final
"Kernan, 2002",Insulin Resistance / Impaired glucose metabolism,Atherosclerosis,Increase,4.0,16,Final
"Kernan, 2002",Age,Insulin Resistance / Impaired glucose metabolism,Increase,4.0,16,Final
,Physical Inactivity,Obesity,Increase,4.61,16,Final
Kernan et al. 2002,Insulin Resistance / Impaired glucose metabolism,Hypertension,Increase,4.0,16,Final
Kernan et al 2002,Insulin Resistance / Impaired glucose metabolism,Dyslipidemia,Increase,2.0,16,Final
Kernan et al 2002,Insulin Resistance / Impaired glucose metabolism,Inflammation,Increase,4.0,16,Final
"Hansson , 2006",Inflammation,Atherosclerosis,Increase,4.17,16,Final
Kahn et. al 2006,Obesity,Insulin Resistance / Impaired glucose metabolism,Increase,4.0,16,Final
Kahn et. al 2006,Obesity,Inflammation,Increase,4.17,16,Final
"Hering, 2015",Psychogenic Stress,Sympathetic activation,Increase,0.51,16,Final
"Hering, 2015",Sympathetic activation,Thrombosis,Increase,0.51,16,Final
Redline et al 2011,Sleep disturbances / Obstructive Sleep Apnea,Hypertension,Increase,0.51,16,Final
Redline et al 2011,Sleep disturbances / Obstructive Sleep Apnea,Insulin Resistance / Impaired glucose metabolism,Increase,2.68,16,Final
Redline et al 2011,Sleep disturbances / Obstructive Sleep Apnea,Inflammation,Increase,1.4,16,Final
,Psychogenic Stress,Smoking,Increase,2.68,16,Final
,Insulin Resistance / Impaired glucose metabolism,Prediabetes,Increase,2.68,16,Final
Fonville et al. 2014,Prediabetes,Diabetes,Increase,2.68,16,Final
,Hypertension,Arterial Dissection,Increase,2.68,16,Final
,Smoking,Hypertension,Increase,2.68,16,Final
American Heart Association 2014,Antihypertensive Therapy,Hypertension,Decrease,4.61,16,Final
American Heart Association 2014,Statin Therapy,Dyslipidemia,Decrease,4.61,16,Final
Hansson 2006,Statin Therapy,Inflammation,Decrease,3.44,16,Final
Kernan et al 2002,Weight Loss and Aerobic Exercise,Insulin Resistance / Impaired glucose metabolism,Decrease,3.44,16,Final
American Heart Association 2014,Dietary salt restriction,Hypertension,Decrease,3.44,16,Final
American Heart Association 2014,Weight Loss and Aerobic Exercise,Physical Inactivity,Decrease,2.68,16,Final
American Heart Association 2014,Healthy Diet,Obesity,Decrease,2.68,16,Final
American Heart Association 2014,Glycemic control,Diabetes,Decrease,2.68,16,Final
Kernan et al 2002,Thiazolidindione,Dyslipidemia,Decrease,2.25,16,Final
Kernan et al 2002,Thiazolidindione,Hypertension,Decrease,2.25,16,Final
Kernan et al 2002,Thiazolidindione,Insulin Resistance / Impaired glucose metabolism,Decrease,2.25,16,Final
American Diabetes Association 2020,SGLT2 Inhibitors,Diabetes,Decrease,2.25,16,Final
American Diabetes Association 2020,GLP1 Receptor Agonists,Diabetes,Decrease,2.25,16,Final
American Heart Association 2014,CPAP Treatment,Sleep disturbances / Obstructive Sleep Apnea,Decrease,2.25,16,Final
American Heart Association 2014,Smoking Cessation,Smoking,Decrease,2.25,16,Final
American Heart Association 2014,Carotid Endarterectomy / Angioplasty / stenting,Atherosclerosis,Decrease,3.07,16,Final
American Heart Association 2014,Mono-/Dual Antiplatelet Therapy,Thrombosis,Decrease,3.0,16,Final
American Heart Association 2014,Anticoagulation Therapy,Embolism,Decrease,3.07,16,Final
American Heart Association 2014,Mono-/Dual Antiplatelet Therapy,Arterial Dissection,Decrease,2.68,16,Final
American Heart Association 2014,Anticoagulation Therapy,Arterial Dissection,Decrease,2.68,16,Final
American Heart Association 2014,Anticoagulation Therapy,Hypercoagulopathy,Decrease,2.68,16,Final
Harrison internal medicine 2020,Statin Therapy,Thrombosis,Decrease,2.68,16,Final
Harrison internal medicine 2020,Statin Therapy,Hypertension,Decrease,2.68,16,Final
Sundell 2008 & mostofsky 2016,Low-Moderate Alcohol Consumption,Atherosclerosis,Decrease,2.0,16,Final
Sundell 2008 & mostofsky 2016,Heavy Alcohol Consumption,Hypertension,Increase,2.0,16,Final
Sundell 2008 & mostofsky 2016,Heavy Alcohol Consumption,Cardiac Remodelling,Increase,2.0,16,Final
Sundell 2008 & mostofsky 2016,Heavy Alcohol Consumption,Atrial Fibrillation,Increase,2.0,16,Final
Sundell 2008 & mostofsky 2016,Heavy Alcohol Consumption,Thrombosis,Increase,2.0,16,Final
American Heart Association 2014,Reducing Alcohol Consumption,Heavy Alcohol Consumption,Decrease,2.0,16,Final
,First Ischemic Stroke,Neurological Sequalae,Increase,2.68,16,Final
,First Ischemic Stroke,Death,Increase,2.68,16,Final
,First Ischemic Stroke,Recurrent Stroke,Increase,2.68,16,Final
Dirnagl Review,first stroke,cerebral inflammation,Increase,6.0,17,Draft
Dirnagl Review,systemic inflammation,first stroke,Increase,6.84,17,Draft
Meisel Review NEJM/Nature,first stroke,peripheral immune competence,Decrease,6.84,17,Draft
,first stroke,large infarction,Increase,6.84,19,Draft
,first stroke,pneumonia,Increase,6.84,19,Draft
,large infarction,pneumonia,Increase,6.84,19,Draft
,pneumonia,death,Increase,6.84,19,Draft
,first stroke,death,Increase,6.84,19,Draft
,first stroke,second stroke,Increase,6.84,19,Draft
,second stroke,pneumonia,Increase,6.84,19,Draft
,second stroke,death,Increase,6.84,19,Draft
,first stroke,depression,Increase,6.84,19,Draft
,depression,immobility,Increase,6.84,19,Draft
,immobility,pneumonia,Increase,6.84,19,Draft
,first stroke,immobility,Increase,6.84,19,Draft
,immobility,death,Increase,6.84,19,Draft
,first stroke,cognitive decline,Increase,6.84,19,Draft
,pneumonia,cognitive decline,Increase,5.1,19,Draft
,cognitive decline,death,Increase,2.79,19,Draft
,second stroke,cognitive decline,Increase,2.79,19,Draft
,hypertension,first stroke,Increase,6.84,19,Draft
,hypertension,second stroke,Increase,6.84,19,Draft
,hypertension,cognitive decline,Increase,5.31,19,Draft
,first stroke,infarct localisation,Increase,6.84,19,Draft
,infarct localisation,cognitive decline,Increase,6.84,19,Draft
,infarct localisation,immunodepression,Increase,6.84,19,Draft
,immunodepression,pneumonia,Increase,6.84,19,Draft
,immunodepression,cognitive decline,Decrease,0.51,19,Draft
,diabetes mellitus,second stroke,Increase,6.84,19,Draft
,diabetes mellitus,first stroke,Increase,6.84,19,Draft
,diabetes mellitus,cognitive decline,Increase,4.61,19,Draft
,first stroke,spasticity,Increase,6.84,19,Draft
,second stroke,spasticity,Increase,6.84,19,Draft
,spasticity,immobility,Increase,6.84,19,Draft
,spasticity,pain,Increase,6.84,19,Draft
,pain,immobility,Increase,6.84,19,Draft
,female,large infarction,Increase,4.8,19,Draft
,depression,female,Increase,4.8,19,Draft
,large infarction,severe disability,Increase,6.84,19,Draft
,severe disability,immobility,Increase,6.84,19,Draft
,first stroke,dysphagia,Increase,6.84,19,Draft
,second stroke,dysphagia,Increase,6.84,19,Draft
,dysphagia,pneumonia,Increase,6.84,19,Draft
,dysphagia,malnutrition,Increase,6.84,19,Draft
,first stroke,cachexia,Increase,4.8,19,Draft
,second stroke,cachexia,Increase,4.34,19,Draft
,malnutrition,cachexia,Increase,6.84,19,Draft
,cachexia,death,Increase,4.8,19,Draft
,malnutrition,death,Increase,3.14,19,Draft
,immobility,reduced QoL/ADL,Increase,6.84,19,Draft
,spasticity,reduced QoL/ADL,Increase,6.84,19,Draft
,dysphagia,reduced QoL/ADL,Increase,6.84,19,Draft
,pain,reduced QoL/ADL,Increase,6.84,19,Draft
,cognitive decline,reduced QoL/ADL,Increase,6.84,19,Draft
,first stroke,reduced QoL/ADL,Increase,6.84,19,Draft
,second stroke,reduced QoL/ADL,Increase,6.84,19,Draft
,second stroke,aphasia,Increase,6.84,19,Draft
,first stroke,aphasia,Increase,6.84,19,Draft
,aphasia,reduced QoL/ADL,Increase,6.84,19,Draft
,age,first stroke,Increase,6.84,19,Draft
,age,cognitive decline,Increase,6.84,19,Draft
,age,pneumonia,Increase,6.84,19,Draft
,immobility before stroke,first stroke,Increase,6.0,19,Draft
,immobility,second stroke,Increase,6.0,19,Draft
,depression before stroke,first stroke,Increase,6.84,19,Draft
,pneumonia,antibiotics,Increase,6.84,19,Draft
,antibiotics,death,Decrease,6.84,19,Draft
,depression,antidepressants,Increase,6.84,19,Draft
,antidepressants,reduced QoL/ADL,Decrease,4.26,19,Draft
,speech therapy,aphasia,Decrease,6.84,19,Draft
,psychotherapy,depression,Decrease,6.84,19,Draft
,psychotherapy,cognitive decline,Decrease,2.38,19,Draft
,physiotherapy,immobility,Decrease,6.84,19,Draft
,physiotherapy,severe disability,Decrease,6.84,19,Draft
,social work,reduced QoL/ADL,Decrease,6.84,19,Draft
,secondary prevention,second stroke,Decrease,6.84,19,Draft
,primary prevention,first stroke,Decrease,6.84,19,Draft
,physical exercise,first stroke,Decrease,6.84,19,Draft
,physical exercise,second stroke,Decrease,6.84,19,Draft
,physical exercise,cognitive decline,Decrease,6.84,19,Draft
,care giving,death,Decrease,4.08,19,Draft
,social work,care giving,Increase,3.07,19,Draft
,multimodal pain therapy,pain,Decrease,6.84,19,Draft
,botolinum toxin,spasticity,Decrease,6.84,19,Draft
,cognitive training,cognitive decline,Decrease,5.0,19,Draft
Christoph,hypertension,first ischemic stroke,Increase,6.84,20,Draft
Christoph,hypertension,second ischemic stroke,Increase,6.84,20,Draft
Christoph,first ischemic stroke,second ischemic stroke,Increase,6.84,20,Draft
Christoph,first ischemic stroke,death,Increase,6.84,20,Draft
Christoph,second ischemic stroke,death,Increase,6.84,20,Draft
Christoph,aging,recovery level,Decrease,6.84,20,Draft
Christoph,aging,death,Increase,6.84,20,Draft
Christoph,aging,first ischemic stroke,Increase,6.84,20,Draft
Christoph,aging,second ischemic stroke,Increase,6.84,20,Draft
Christoph,second ischemic stroke,recovery level,Decrease,6.84,20,Draft
,first ischemic stroke,recovery level,Decrease,2.68,20,Draft
,B-cell infiltration,cognition,Decrease,2.68,20,Draft
,aging,cognition,Decrease,6.84,20,Draft
,hypertension,cognition,Decrease,4.08,20,Draft
,first ischemic stroke,cognition,Decrease,2.06,20,Draft
,second ischemic stroke,cognition,Decrease,6.84,20,Draft
,systemic IL6,recovery level,Decrease,6.0,20,Draft
,brain IL6_time1,recovery level,Increase,6.0,20,Draft
,systemic IL6,second ischemic stroke,Increase,6.84,20,Draft
,systemic IL6,second ischemic stroke,Increase,6.84,20,Draft
,systemic IL6,first ischemic stroke,Increase,6.84,20,Draft
,collateralization,stroke volume,Increase,6.84,20,Draft
,first ischemic stroke,hemispheric atrophy,Increase,6.84,20,Draft
,second ischemic stroke,hemispheric atrophy,Increase,6.84,20,Draft
,hypertension,hemispheric atrophy,Increase,3.68,20,Draft
,aging,hemispheric atrophy,Increase,6.84,20,Draft
,endothelial proliferation,recovery level,Increase,6.84,20,Draft
,endothelial proliferation,blood brain barrier integrity,Decrease,6.84,20,Draft
,blood brain barrier integrity,B-cell infiltration,Increase,6.84,20,Draft
,microglial proliferation,neuronal survival,Decrease,6.84,20,Draft
,brain IL6_time2,recovery level,Decrease,2.68,20,Draft
,astrocytic proliferation,recovery level,Increase,2.68,20,Draft
,astrocytic proliferation,neuronal survival,Increase,2.68,20,Draft
,endothelial proliferation,neuronal survival,Increase,5.2,20,Draft
,collateralization,first ischemic stroke,Decrease,5.2,20,Draft
,collateralization,second ischemic stroke,Decrease,5.2,20,Draft
